< Back to previous page
Researcher
Robert Snoeck
- Disciplines:Microbiology, Systems biology, Laboratory medicine
Affiliations
- Laboratory of Virology and Chemotherapy (Rega Institute) (Division)
Member
From1 Oct 1999 → Today
Projects
1 - 10 of 15
- Viral Oncology: molecular biology and pathogenesis of post-transplant lymphoproliferative disorder (PTLD)From13 Sep 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Dynamics of cytomegalovirus infection: evolution towards antiviral drug resistanceFrom1 Feb 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Intravital microscopy platform for infectious and inflammatory diseasesFrom1 May 2020 → TodayFunding: FWO Medium Size Research Infrastructure
- Challenges and opportunities in the management of herpesvirus antiviral-resistanceFrom17 Apr 2018 → 17 Apr 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
- Unravelling the role of BK polyomavirus genetic variants in viral pathogenicity and clearance in kidney transplant recipientsFrom1 Apr 2018 → 8 Mar 2024Funding: Own budget, for example: patrimony, inscription fees, gifts
- Challenges and opportunities in the management of herpesvirus antiviral-resistanceFrom1 Jan 2018 → 31 Dec 2021Funding: FWO research project (including WEAVE projects)
- Unraveling the role of BK polyomavirus variants and of cellular CMP kinase on viral pathogenicity and clearance in renal-transplant patientsFrom1 Oct 2017 → 30 Sep 2021Funding: FWO Applied Biomedical Research (TBM)
- Automated real-time quantitative live cell analysisFrom1 Oct 2016 → 30 Sep 2018Funding: Fund Recuperation Fiscal Exemption
- The role of Tumor Micro-Environment in the pathogenesis and prognosis of EBV lymphomas: a study in human tumor biopsies and an novel Patient Derived Tumor Xenograft mouse modelFrom1 Sep 2016 → 25 Nov 2020Funding: Private funding of national origin - undefined
- MERKEL CELL CARCINOMA, TOWARDS THE IDENTIFICATION OF NOVEL MOLECULAR TARGETS AND THE ESTABLISHMENT OF A THREE-DIMENSIONAL CELL CULTURE MODELFrom9 Nov 2015 → 14 Dec 2020Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 10 of 235
- Peptidomimetics as potent dual SARS-CoV-2 cathepsin-L and main protease inhibitors: In silico design, synthesis and pharmacological characterization(2024)
Authors: Robert Snoeck, Graciela Andrei
- A Herpes Simplex Virus 1 DNA Polymerase Multidrug Resistance Mutation Identified in a Patient With Immunodeficiency and Confirmed by Gene Editing(2023)
Authors: Hanna Schalkwijk, Graciela Andrei, Robert Snoeck
Pages: 1505 - 1515 - An observational cohort study of histological screening for BK polyomavirus nephropathy following viral replication in plasma(2023)
Authors: Evert Cleenders, Elisabet Van Loon, Katrien Lagrou, Graciela Andrei, Katrien De Vusser, Dirk Kuypers, Olga Mineeva-Sangwo, Robert Snoeck, Marc Van Ranst, Geert Verbeke, et al.
Pages: 1018 - 1034 - Synthesis of new 3-acetyl-1,3,4-oxadiazolines combined with pyrimidines as antileishmanial and antiviral agents(2023)
Authors: Johan Neyts, Dirk Jochmans, Graciela Andrei, Robert Snoeck
Pages: 2147 - 2159 - Differences in pathogenicity among the mpox virus clades: impact on drug discovery and vaccine development(2023)
Authors: Graciela Andrei, Robert Snoeck
Pages: 719 - 739 - PRO-2000 exhibits SARS-CoV-2 antiviral activity by interfering with spike-heparin binding(2023)
Authors: Evelien Vanderlinden, Arnaud Boonen, Sam Noppen, Maya Imbrechts, Robert Snoeck, Annelies Stevaert, Lieve Naesens, Graciela Andrei, Dominique Schols
- Time-dependent variations in BK polyomavirus genome from kidney transplant recipients with persistent viremia(2023)
Authors: Olga Mineeva-Sangwo, Elisabet Van Loon, Graciela Andrei, Dirk Kuypers, Maarten Naesens, Robert Snoeck
- Synthesis and anti-SARS-CoV-2 evaluation of lipid prodrugs of ?-D-N4-hydroxycytidine (NHC) and a 3?-fluoro-substituted analogue of NHC(2023)
Authors: Piet Herdewyn, Robert Snoeck, Graciela Andrei
- Synthesis of 1-[ω-(Bromophenoxy)alkyl]-3-naphthalenylmethyl Derivatives of Uracil and Their Analogues As Probable Inhibitors of Human Cytomegalovirus Replication(2023)
Authors: Robert Snoeck, Graciela Andrei
Pages: 41 - 46 - Design and synthesis of a new series of hybrids of functionalised N 1-[(1H-1,2,3-triazol- 4-yl)methyl]quinazoline-2,4-dione with antiviral activity against Respiratory Syncytial Virus(2023)
Authors: Robert Snoeck, Emiel Vanhulle, Mirthe Graus, Graciela Andrei, Dominique Schols, Kurt Vermeire
Patents
1 - 6 of 6
- Prodrugs of nucleoside phosphonates (Inventor)
- Novel prodrugs of nucleoside phosphonates (Inventor)
- Novel purine derivatives and drugs comprising same (Inventor)
- Prodrugs of fluorinated acyclic nucleoside phosphonates (Inventor)
- Prodrugs of fluorinated acyclic nucleoside phosphonates (Inventor)
- Novel prodrugs of nucleoside phosphonates (Inventor)